Developer docs
API playgroundTry for free, no card

Search company profiles

Precipart

Full company profile

uuid0004n4z

Namestring
Precipart
Websiteurl
precipart.com
Company typeenum
Private
Founded yearint
1950
Descriptiontext

Precipart is a US-based contract manufacturer founded in 1950 and headquartered in Farmingdale, New York, specializing in highly engineered precision components for the medical device and aerospace industries. The company operates manufacturing capabilities in CNC machining, ceramic injection molding, and micro-manufacturing to produce tight-tolerance parts for implants, surgical instruments, diagnostic equipment, aircraft systems, engines, and instrumentation. Its core value proposition is engineering expertise applied to mission-critical applications requiring stringent quality, reliability, and regulatory compliance.

Precipart generates revenue through B2B contract manufacturing services sold directly to OEM customers via enterprise field sales relationships. Pricing is quote-based and not publicly disclosed, with revenue likely structured as a mix of one-time tooling/setup fees and recurring production volume revenue. The primary customer segment is medical device manufacturers, with aerospace as a secondary vertical. The company employs between 251 and 500 people.

In October 2023, Precipart received a growth investment from KKR's Health Care Strategic Growth Fund II, with stated objectives to expand global presence, grow capability offerings within the medical device sector, and pursue both organic and inorganic expansion. The company also received a small US Department of Energy award in the same period. The company is privately held and led by CEO Oliver Laubscher.

Short descriptiontext

Precipart is a US-based contract manufacturer founded in 1950 that produces highly engineered precision components—including CNC-machined, ceramic injection-molded, and micro-manufactured parts—for medical device and aerospace OEM customers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersFarmingdale, United States
HQ citystring
Farmingdale
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
precision contract manufacturing, medical device components, aerospace precision parts, motion control systems, ceramic injection molding
Industry1 code
1Precision & Micro Injection Molding
CodeIMANAFAHPrimaryYes
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Screw Machine Products3451
Product category
Precision Contract Manufacturing
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Manufacturing Services
TypeOne Time License
Description

Precipart generates revenue through contract manufacturing of highly engineered precision components for medical device and aerospace industries. Revenue is likely derived from production contracts, likely with a mix of one-time tooling/setup fees and recurring production revenue based on unit volumes.

media.kkr.com
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Precipart is a contract manufacturer that produces highly engineered precision components for medical device and aerospace OEM customers. Capabilities span CNC machining, additive manufacturing, ceramic injection molding, micro manufacturing, and motion control system production for implants, surgical instruments, diagnostic equipment, aircraft systems, and instrumentation.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Precipart is a contract manufacturer specializing in highly engineered precision components for the medical device and aerospace industries. As a precision parts manufacturer, the company operates as a single-product service offering focused on custom manufacturing capabilities rather than a platform-plus-modules architecture. No specific named products, sub-products, or modules were identified in the available source data. The company's value proposition centers on CNC machining, additive manufacturing capabilities, and precision engineering expertise serving instrumentation, medical device, and aerospace sectors.

Product and service4 records
1Motion Control Systems
CategoryPrecision Contract Manufacturing
Description

Engineered motion control systems manufactured for medical device and aerospace OEM customers requiring precision actuation components.

2Ceramic Injection Molding
CategoryPrecision Contract Manufacturing
Description

Custom ceramic injection molding services producing precision ceramic components for medical device and aerospace applications.

3Micro Manufacturing
CategoryPrecision Contract Manufacturing
Description

Micro-scale manufacturing of highly engineered precision components for demanding medical and aerospace applications.

4Highly Engineered Precision Components (CNC Machining & Additive Manufacturing)
CategoryPrecision Contract Manufacturing
Description

Contract manufacturing of tight-tolerance precision components via CNC machining and additive manufacturing for medical device and aerospace OEM customers.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks1 record

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Precipart

Precision Contract Manufacturingprecipart.com

Precipart is a US-based contract manufacturer founded in 1950 that produces highly engineered precision components—including CNC-machined, ceramic injection-molded, and micro-manufactured parts—for medical device and aerospace OEM customers.

What Precipart does

Precipart is a US-based contract manufacturer founded in 1950 and headquartered in Farmingdale, New York, specializing in highly engineered precision components for the medical device and aerospace industries. The company operates manufacturing capabilities in CNC machining, ceramic injection molding, and micro-manufacturing to produce tight-tolerance parts for implants, surgical instruments, diagnostic equipment, aircraft systems, engines, and instrumentation. Its core value proposition is engineering expertise applied to mission-critical applications requiring stringent quality, reliability, and regulatory compliance.

Precipart generates revenue through B2B contract manufacturing services sold directly to OEM customers via enterprise field sales relationships. Pricing is quote-based and not publicly disclosed, with revenue likely structured as a mix of one-time tooling/setup fees and recurring production volume revenue. The primary customer segment is medical device manufacturers, with aerospace as a secondary vertical. The company employs between 251 and 500 people.

In October 2023, Precipart received a growth investment from KKR's Health Care Strategic Growth Fund II, with stated objectives to expand global presence, grow capability offerings within the medical device sector, and pursue both organic and inorganic expansion. The company also received a small US Department of Energy award in the same period. The company is privately held and led by CEO Oliver Laubscher.

Precipart firmographics

Firmographics
Name
Precipart
Website
https://precipart.com
Company type
Private
Founded year
1950
Operating status
Operating
Headcount range
251–500 employees
Short description
Precipart is a US-based contract manufacturer founded in 1950 that produces highly engineered precision components—including CNC-machined, ceramic injection-molded, and micro-manufactured parts—for medical device and aerospace OEM customers.
Ownership category
akta.pro rank

Precipart industry classification

Industry
Product category
Precision Contract Manufacturing
NAICS
Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Screw Machine Products (3451)
akta.pro primary industry
Precision & Micro Injection Molding (IMANAFAH)

Keywords

  • Precision contract manufacturing
  • Medical device components
  • Aerospace precision parts
  • Motion control systems
  • Ceramic injection molding

Where Precipart is headquartered

Location

Headquarters

HQ city
Farmingdale
HQ country
United States
HQ region
North America

Markets served

Precipart business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure

Revenue model

  1. Contract Manufacturing Services: Precipart generates revenue through contract manufacturing of highly engineered precision components for medical device and aerospace industries. Revenue is likely derived from production contracts, likely with a mix of one-time tooling/setup fees and recurring production revenue based on unit volumes.

Go-to-market motion1 record

Distribution channels1 record

Precipart product offering

Product offering

Core offering

Precipart is a contract manufacturer that produces highly engineered precision components for medical device and aerospace OEM customers. Capabilities span CNC machining, additive manufacturing, ceramic injection molding, micro manufacturing, and motion control system production for implants, surgical instruments, diagnostic equipment, aircraft systems, and instrumentation.

Product overview

Precipart is a contract manufacturer specializing in highly engineered precision components for the medical device and aerospace industries. As a precision parts manufacturer, the company operates as a single-product service offering focused on custom manufacturing capabilities rather than a platform-plus-modules architecture. No specific named products, sub-products, or modules were identified in the available source data. The company's value proposition centers on CNC machining, additive manufacturing capabilities, and precision engineering expertise serving instrumentation, medical device, and aerospace sectors.

Differentiator

Problem solved

Functional benefit

Products and services

  • Motion Control Systems Engineered motion control systems manufactured for medical device and aerospace OEM customers requiring precision actuation components.
  • Ceramic Injection Molding Custom ceramic injection molding services producing precision ceramic components for medical device and aerospace applications.
  • Micro Manufacturing Micro-scale manufacturing of highly engineered precision components for demanding medical and aerospace applications.
  • Highly Engineered Precision Components (CNC Machining & Additive Manufacturing) Contract manufacturing of tight-tolerance precision components via CNC machining and additive manufacturing for medical device and aerospace OEM customers.

Companies that use Precipart

Customer profile

Segments2 records

Ideal customer profiles2 records

Precipart technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Precipart partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves3 records

Expansion highlights5 records

Precipart competitors and assessment

Company assessment

Market position

Weaknesses5 records

Competitive moat3 records

Key risks1 record

Key highlights6 records

Customer concentration

Precipart social profiles

Digital presence

Precipart financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Precipart leadership team

Management profile

Number of profiles

Profiles1 record

Precipart funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Precipart M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Precipart

What does Precipart do?

Precipart is a contract manufacturer that produces highly engineered precision components for medical device and aerospace OEM customers. Capabilities span CNC machining, additive manufacturing, ceramic injection molding, micro manufacturing, and motion control system production for implants, surgical instruments, diagnostic equipment, aircraft systems, and instrumentation.

Is Precipart a public or private company?

Precipart is a private company. It is classified as private equity controlled and is currently operating.

When was Precipart founded?

Precipart was founded in 1950. It employs 251 to 500 people.

Where is Precipart based?

Precipart is headquartered in Farmingdale, United States, in the North America region.

How does Precipart make money?

One revenue line is on record: contract Manufacturing Services.

Does Precipart have an API?

No public API is recorded for Precipart.

What industry is Precipart in?

Precipart's product category is Precision Contract Manufacturing. Its primary akta.pro industry code is IMANAFAH, Precision & Micro Injection Molding. Its NAICS code is 339112 and its SIC code is 3451.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FierceBiotechKKR-backed Allyntra debuts to serve medtech industry as it announces new CEOGlobal investment firm KKR has launched Allyntra as a new precision-engineered solutions platform for the medtech industry, appointing Robbie Atkinson as CEO and Brian Highly as board chair. Precipart, a precision components company for medical devices and aerospace in which KKR first invested in 2023, forms a key component of this new platform strategy. The debut aligns with KKR's broader healthcare investment approach, including a recent $1 billion partnership with BridgeBio for its heart disease drug launch.ThemiddlemarketKKR Launches Allyntra to Build Engineered Services PlatformKKR has launched Allyntra, a newly formed precision-engineered services platform focused on the medical technology sector, built around Precipart which KKR acquired through its Health Care Strategic Growth Fund II in 2023. Robbie Atkinson has been appointed CEO of Allyntra, with Brian Highley serving as chairman, while Oliver Laubscher steps down as CEO of Precipart to join the Allyntra board of directors. The platform launch represents KKR's strategy to consolidate precision engineering capabilities in the medical technology and demanding industries space.GurufocusKKR Launches Allyntra, an Engineered Solutions Platform for MediKKR announced the launch of Allyntra, a newly formed precision-engineered solutions platform serving medical technology and other precision end markets, building on its existing investment in Precipart through its Health Care Strategic Growth Fund II. Robbie Atkinson has been appointed as Chief Executive Officer and Brian Highley as Chairman of Allyntra, both bringing extensive experience in the medical technology manufacturing industry. KKR is committing additional capital to support Allyntra's growth through acquisitions of complementary businesses and continued investment in innovation and commercial expansion.Business Wire BlogKKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision IndustriesKKR announced the launch of Allyntra, a newly formed precision-engineered solutions platform serving medical technology and other precision end markets, building on KKR's existing investment in Precipart from 2023. Robbie Atkinson has been appointed as CEO and Brian Highley as Chairman of the new platform, both bringing extensive experience in scaling global manufacturing organizations. KKR is committing additional capital to support Allyntra's growth through acquisitions of complementary businesses and continued investment in innovation and commercial expansion.FinancialContent Business PageKKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision IndustriesKKR announced the launch of Allyntra, a newly formed precision-engineered solutions platform serving medical technology and other precision end markets, with Robbie Atkinson appointed as CEO and Brian Highley as Chairman. The platform builds on KKR's existing investment in Precipart, which will serve as one of the foundational businesses, with KKR committing meaningful additional capital to support growth through acquisitions and continued investment in innovation. Oliver Laubscher will elevate to join Allyntra's Board of Directors, transitioning from his role as CEO of Precipart, as the Laubscher family remains a meaningful shareholder.Stock TitanKKR launches Allyntra medical tech platformKKR announced the launch of Allyntra, a newly formed precision-engineered solutions platform serving medical technology and precision industries, building on its existing investment in Precipart through its Health Care Strategic Growth Fund II. The firm is committing meaningful additional capital to support Allyntra's growth through acquiring and integrating complementary businesses, with Robbie Atkinson appointed as CEO and Brian Highley as Chairman. Oliver Laubscher will join the Allyntra Board and transition from his role as CEO of Precipart, while the Laubscher family will remain a meaningful shareholder.GlobeNewswireInstrumentation Precision Parts Research Report 2025: A $9.64 Billion Market by 2030, Driven by High Adoption of Smart Sensors, Compact Precision Components and Next-Generation Production TechniquesThe article reports on the projected growth of the instrumentation precision parts market from USD 7.50 billion in 2024 to USD 9.64 billion by 2030, with a CAGR of 4.27%, driven by demand in sectors such as aerospace, automotive, electronics, and industrial automation. The market growth is fueled by technological innovations like CNC machining, additive manufacturing, and smart automation, especially in the APAC region led by China, Japan, and South Korea. Major companies like Gemson and Precipart are actively advancing market competitiveness through innovation and product expansion.ZoominfoPrecipart - Overview, News & Similar companiesKKR, a leading global investment firm, has agreed to invest in Precipart Group, a manufacturer of precision mechanical components and motion control devices. The financial terms of the transaction were not disclosed, but KKR plans to support Precipart's continued growth through organic expansion and mergers and acquisitions. Precipart was founded in 1950 and retains significant minority ownership by its founding Laubscher family.Top WorkplacesWorking at PrecipartPrecipart is a global company that designs, manufactures and engineers high-precision custom solutions for medical, aerospace and industrial markets, offering mechanical components, assemblies, gears and motion control. Its offices are located in Switzerland, the U.S., the U.K. and India.PitchBookPrecipart 2025 Company Profile: Valuation, Funding & InvestorsA PitchBook company profile page presents a preview of data on Precipart, a private manufacturer of motion control components for medical, aerospace and industrial markets. The page lists the company as founded in 1950, headquartered in Farmingdale, NY, with 270 employees and two financing rounds, and notes Kohlberg Kravis Roberts as an investor. Financial figures, valuation and investor details are gated behind a platform trial.